Eyevensys closes on $30 million Series B financing

January 10, 2020
Eyevensys, a Paris-based biotechnology company, has closed a round of $30 million in Series B financing intended for development of EYS606 for the…
Blog

BLOG: Why my practice has evolved toward a personalized vision approach

January 9, 2020
Although we have enjoyed great success with bilateral extended depth of focus IOLs in patients who want spectacle independence after cataract…

Aerpio’s AKB-9778 as adjunct reduces IOP in phase 1b trial

January 9, 2020
A topical ocular formulation of AKB-9778 given as an adjunctive therapy reduced IOP and was well tolerated in patients with ocular hypertension or…

VisionWatch report shows increase in vision care industry

January 9, 2020
The vision care market generated $43.39 billion in retail revenues in the year ending September 2019, according to VisionWatch, a survey conducted by…
Meeting NewsVideo

VIDEO: Combining MIGS for best outcomes

January 9, 2020
NEW YORK — Nathan M. Radcliffe, MD, discusses combining MIGS and medication and the possibility of combining MIGS procedures in the future…

SECO 20/20 expands advanced learning methods at annual conference

January 9, 2020
SECO 20/20 will launch new and diverse methods for idea sharing at its 2020 annual conference. These enhanced methods include the addition of new…
Perspective

CPT codes available for Notal Vision’s home OCT system

January 9, 2020
Three new Category III codes have been established for Notal Vision’s home OCT system by the American Medical Association’s CPT Editorial…
In the Journals

Researchers identify ways to improve physician-patient visits

January 9, 2020
Findings of a mixed methods study in JAMA identified five ways to improve patient-physician visits: prepare for a meaningful interaction, listen…

Allysta doses first patient in phase 1/2a dry eye trial

January 8, 2020
The first patient has been dosed in a phase 1/2a trial of ALY688, a dry eye treatment candidate, Allysta Pharmaceuticals announced in a press…
Blog

BLOG: How temperature affects concussion recovery

January 8, 2020
by W. Dalton Dietrich III , PhD I’ve been researching the role of mild hypothermia and hyperthermia on health outcomes…
Blog

BLOG: Grow your practice by treating dry eye

January 8, 2020
Treating dry eye is an opportunity to grow your practice, both in numbers and in revenue. As optometrists, we are the primary gatekeepers for our…

AOA encourages employers to endorse eye exams in 2020 program

January 8, 2020
The American Optometric Association is calling upon U.S. companies to join its 2020 Employer Pledge program by supporting annual comprehensive eye…
From OSN Europe

Fight for Sight calls for eye research funding in UK

January 8, 2020
Twelve ophthalmology leaders have signed a public letter to the U.K. government calling for a national plan to address sight loss, according to a…
Meeting NewsVideo

VIDEO: Stents, trabs and tubes: Which procedure and when?

January 8, 2020
NEW YORK — During his presentation at OSN New York 2019, Thomas W. Samuelson, MD, discusses surgical treatment options for glaucoma and when…
Feature

Despite its advantages, experts have ‘grave concerns’ about big tech in health care

January 8, 2020
Google recently began working with Ascension — one of the nation’s largest health care systems — to collect the health information…
Meeting NewsVideo

VIDEO: Should SLT be the preferred first-line treatment?

January 7, 2020
NEW YORK — In her presentation at OSN New York 2019, Valerie Trubnik, MD, FACS, discusses results of the LiGHT trial, which compared selective…

Oxurion’s DME therapy shows positive phase 1 results

January 7, 2020
THR-687, a diabetic macular edema treatment candidate, was shown to be safe and well tolerated in a phase 1 trial, Oxurion announced in a press…
In the Journals

CPAP therapy may lower risk of diabetic retinopathy

January 7, 2020
Researchers found that the prevalence of diabetic retinopathy was lower in patients with sleep apnea who were compliant with continuous positive…
Meeting NewsVideo

VIDEO: New drugs will change glaucoma management

January 7, 2020
NEW YORK — During his presentation at OSN New York 2019, Robert J. Noecker, MD, MBA, discusses pharmacological treatment options for glaucoma…
Meeting NewsVideo

VIDEO: OCT: What should I image –NFL, ganglion cell or both?

January 6, 2020
NEW YORK — At OSN New York 2019, Joel S. Schuman, MD, FACS, discusses the use of OCT for glaucoma. Monitoring the ganglion cell layer, the…